clenbuterol has been researched along with Experimental Leukemia in 1 studies
Clenbuterol: A substituted phenylaminoethanol that has beta-2 adrenomimetic properties at very low doses. It is used as a bronchodilator in asthma.
clenbuterol : A substituted aniline that is 2,6-dichloroaniline in which the hydrogen at position 4 has been replaced by a 2-(tert-butylamino)-1-hydroxyethyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zvetkova, E | 1 |
| Chowdhury, I | 1 |
| Rusev, R | 1 |
| Janeva, E | 1 |
| Nikolova, E | 1 |
| Tzenov, I | 1 |
| Trifonov, S | 1 |
1 other study available for clenbuterol and Experimental Leukemia
| Article | Year |
|---|---|
Influence of the immunomodulators suramin, MER and clenbuterol on the haemopoiesis of mice with virus-induced Rauscher leukemia.
Topics: Adjuvants, Immunologic; Animals; BCG Vaccine; Bone Marrow; Clenbuterol; Drug Evaluation, Preclinical | 1993 |